IRIS
COLUCCI, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.100
EU - Europa 1.764
AS - Asia 520
OC - Oceania 4
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.395
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.095
CN - Cina 474
SE - Svezia 452
DE - Germania 390
UA - Ucraina 250
IT - Italia 226
FI - Finlandia 156
FR - Francia 103
GB - Regno Unito 88
IE - Irlanda 40
BE - Belgio 23
IN - India 22
RU - Federazione Russa 18
CA - Canada 5
NL - Olanda 5
IR - Iran 4
KR - Corea 4
VN - Vietnam 4
AU - Australia 3
EU - Europa 3
AR - Argentina 2
BR - Brasile 2
IL - Israele 2
PL - Polonia 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
ES - Italia 1
GR - Grecia 1
HK - Hong Kong 1
HU - Ungheria 1
ID - Indonesia 1
IS - Islanda 1
KW - Kuwait 1
LU - Lussemburgo 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RO - Romania 1
SG - Singapore 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 10.395
Salva come PNG Salva come JPEG
Città #
Fairfield 1.170
Woodbridge 1.039
Houston 692
Chandler 679
Jacksonville 606
Ashburn 556
Seattle 508
Cambridge 418
Ann Arbor 404
Wilmington 388
Nyköping 387
Roxbury 162
Lawrence 160
Nanjing 158
Des Moines 96
Beijing 87
Bari 86
Boardman 69
New York 65
Princeton 61
San Diego 61
Inglewood 53
Strasbourg 49
Hebei 42
Brooklyn 41
Nanchang 41
Dublin 39
Shenyang 39
Grafing 37
Tianjin 25
Brussels 23
Dearborn 21
Changsha 19
Jiaxing 18
London 17
Paris 17
Pune 15
Los Angeles 12
Auburn Hills 10
Redwood City 10
Kunming 9
San Mateo 9
Jinan 8
Augusta 7
Foggia 6
Zhengzhou 6
Mola Di Bari 5
Norwalk 5
Rome 5
Dong Ket 4
Helsinki 4
Milan 4
Napoli 4
Ningbo 4
Toronto 4
Ardabil 3
Bethlehem 3
Chicago 3
Detroit 3
Guangzhou 3
Hounslow 3
Indiana 3
Leawood 3
Lecce 3
Monmouth Junction 3
San Francisco 3
San Pietro in Cariano 3
Chongqing 2
Cutrofiano 2
Guagnano 2
Kilburn 2
La Plata 2
Melbourne 2
Monopoli 2
Mumbai 2
Noci 2
Rogeno 2
Salerno 2
Salsomaggiore Terme 2
São Paulo 2
Taranto 2
Tel Aviv 2
Trento 2
Washington 2
Altamura 1
Amsterdam 1
Andria 1
Artogne 1
Barletta 1
Battipaglia 1
Bitonto 1
Bologna 1
Brampton 1
Bratislava 1
Brescia 1
Budapest 1
Cagliari 1
Canberra 1
Cesena 1
Changchun 1
Totale 8.550
Salva come PNG Salva come JPEG
Nome #
Platelet drop and fibrinolytic shutdown in patients with sepsis 120
Histones differentially modulate the anticoagulant and profibrinolytic activities of heparin, heparin derivatives and dabigatran. 118
Coagulation activation is associated with nicotinamide adenine dinucleotide phosphate oxidase-dependent reactive oxygen species generation in hemodialysis patients. 113
Factor IX-Padua enhances the fibrinolytic resistance of plasma clots 113
Dabigatran but not rivaroxaban or apixaban treatment decreases fibrinolytic resistance in patients with atrial fibrillation 108
Cultured human endothelial cells generate tissue factor in response to endotoxin 105
Influence of cell-associated tissue factor concentration on the anticoagulant activity of dabigatran. A possible explanation for the reduced incidence of intracranial bleeding 105
Tissue factor in health and disease 104
Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors 104
Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism 102
Coagulopathy of Acute Sepsis 102
Co-administration of low molecular weight heparin enhances the profibrinolytic effect of warfarin through different mechanisms. 101
A modified prothrombin time to measure the anticoagulant activity of dabigatran 101
In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis. Study in healthy subjects and correlation with blood fibrinolytic parameters 98
Grape intake reduces thrombin generation and enhances plasma fibrinolysis. Potential role of circulating procoagulant microparticles 98
Effect of warfarin treatment on thrombin activatable fibrinolysis inhibitor (TAFI) activation and TAFI-mediated inhibition of fibrinolysis 97
Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathway 97
Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots 96
Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation 95
Role of leucocyte procoagulant activity in endotoxin-induced DIC: evidence from comparative studies in rats and rabbits. 95
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein C reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation 95
Effect of ochratoxin A on prothrombotic and proinflammatory activities of stimulated blood mononuclear cells 95
A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression 95
Platelets and fibrinolysis 93
Sepsis, thrombosis and organ dysfunction 91
Changes in coagulation-fibrinolysis balance in blood mononuclear cells and in gastric mucosa from patients with Helicobacter pylori infection 90
Fisiologia dell'Emostasi 89
TAFI deficiency in liver cirrhosis: relation with plasma fibrinolysis and survival 88
Reduced generation of procoagulant activity by endotoxin-stimulated mononuclear cells from patients with chronic myeloid leukaemia. 88
FAILURE OF WARFARIN TO AFFECT THE TISSUE FACTOR ACTIVITY AND THE METASTATIC POTENTIAL OF MURINE FIBRO-SARCOMA CELLS. 87
Antithrombotic activity of 12 table grape varieties. Relationship with polyphenolic profile 87
Non neutralizing antibodies to tissue type plasminogen activator in the serum of acute myocardial infarction patients treated with the recombinant protein. 86
Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells 85
CHANGES IN THE COAGULATION-FIBRINOLYSIS BALANCE OF ENDOTHELIAL-CELLS AND MONONUCLEAR PHAGOCYTES - ROLE IN DISSEMINATED INTRAVASCULAR COAGULATION ASSOCIATED WITH INFECTIOUS-DISEASES 85
Complement-dependent and complement-independent interactions of bacterial lipopolysaccharides and mucopeptides with rabbit and human platelets. 84
Thrombolysis enhancing activity of a low molecular weight dermatan sulfate (Desmin 370) in experimental pulmonary embolism in rats. 84
In vitro inhibition of monocyte tissue factor and PAI-2 production by Ochratoxin A 83
Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin-activatable fibrinolysis inhibitor 83
Procoagulant activity of sarcoma sublines with different metastatic potential 82
Monocytes, but not endothelial cells, downregulate the anticoagulant activity of activated protein C 82
Hyperprothrombinemia-induced APC resistance: differential influence on fibrin formation and fibrinolysis 82
Stroke in two young siblings with congenital dysfibrinogenemia. 81
Blood and tissue fibrinolytic profile in patients with colorectal cancer 81
Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies 81
null 80
Treatment with cyclosporin A does not affect macrophage procoagulant activity and plasminogen activator inhibitor in mice 80
Cancer cell procoagulant: a novel vitamin K-dependent activity. 79
Unbalanced coagulation-fibrinolysis potential during L-Asparaginase therapy in children with acute lymphoblastic leukaemia 78
ENHANCED ENDOTHELIAL TISSUE FACTOR BUT NORMAL THROMBOMODULIN IN ENDOTOXIN-TREATED RABBITS. 78
Low D-dimer levels in sepsis: Good or bad? 77
Mild hyperhomocysteinemia is associated with increased TAFI levels and reduced plasma fibrinolytic potential 76
Warfarin inhibits both procoagulant activity and metastatic capacity of Lewis lung carcinoma cells. Role of vitamin K deficiency. 76
Reduction of the plasma levels of tissue plasminogen activator after infusion of a lipid emulsion in humans 76
Helicobacter pylori neutrophil-activating protein stimulates tissue factor and plasminogen activator inhibitor-2 production by human blood mononuclear cells 75
Early increase of a new platelet coagulant activity in rats fed a thrombogenic diet. 75
A hitherto undescribed defect of platelet coagulant activity in polycythaemia vera and essential thrombocythaemia. 75
Cancer cell procoagulant activity: evaluation by an amidolytic assay. 75
Increased mononuclear cell tissue factor and type-2 plasminogen activator inhibitor and reduced plasma fibrinolytic capacity in children with lymphoma 74
Ochratoxin A inhibits the production of tissue factor and plasminogen activator inhibitor-2 by human blood mononuclear cells: Another potential mechanism of immune-suppression 74
FVIII/VWF complex displays a greater pro-hemostatic activity than FVIII preparations devoid of VWF. Study in plasma and cell-based models 74
Does inhibiting Sur1 complement rtPA in cerebral ischemia? 73
Increased macrophage procoagulant activity but normal endothelial thrombomodulin in rabbits fed an atherogenic diet 73
Effect of Ochratoxin A on prothrombotic and proinflammatory activities of stimulated blood mononuclear cells 73
Cultured human mesangial cells produce both type 1 and type 2 plasminogen activator inhibitors 73
EXPERIMENTAL ENDOTOXEMIA AS A MODEL OF IMPAIRED FIBRINOLYSIS 72
REDUCED FIBRINOLYTIC-ACTIVITY IN GLOMERULI ISOLATED FROM RABBITS INFUSED WITH TUMOR-NECROSIS-FACTOR. 72
Rebuttal to: Effect of heparin on TAFI-dependent inhibition of fibrinolysis 72
URINARY PROCOAGULANT AND FIBRINOLYTIC-ACTIVITY IN HUMAN GLOMERULONEPHRITIS - RELATIONSHIP WITH RENAL-FUNCTION 71
Skin extracts from 2 italian table grapes (italia and palieri) inhibit tissue factor expression by human blood mononuclear cells 71
Procoagulant properties of bare and highly-PEGylated vinyl-modified silica nanoparticles 71
The paradoxical antifibrinolytic effect of dabigatran and argatroban in the presence of soluble thrombomodulin is unrelated to protein C-dependent increase of thrombin generation. 70
Fibrin down-regulates LPS- and PMA- induced tissue factor expression by blood mononuclear cells 69
Gene expression signature induced by grape intake in healthy subjects reveals wide-spread beneficial effects on peripheral blood mononuclear cells 68
PLASMINOGEN ACTIVATOR INHIBITOR IN THE BLOOD OF PATIENTS WITH CORONARY-ARTERY DISEASE. 66
Sepsis-associated disseminated intravascular coagulation and thromboembolic disease. 65
Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis 65
Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA 65
Retinoic acid stimulates plasminogen activator inhibitor 2 production by blood mononuclear cells and inhibits urokinase-induced extracellular proteolysis 64
Thrombin Activatable Fibrinolysis Inhibitor: at the nexus of fibrinolysis and inflammation 64
Increased production of mononuclear cell procoagulant activity in Hodgkin's disease. 64
EFFECT OF HEPARIN AND OR ANTITHROMBIN-III ON THE GENERATION OF ENDOTOXIN-INDUCED PLASMINOGEN-ACTIVATOR INHIBITOR. 63
The role of thrombin activatable fibrinolysis inhibitor and factor XI in platelet-mediated fibrinolysis resistance: a thromboelastographic study in whole blood 63
Prevention and therapy of experimental venous thrombosis in rabbits by desmin 370 62
HEMOSTATIC VARIABLES IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - EFFECT OF REGULAR PLASMA-CHOLESTEROL REMOVAL BY LOW-DENSITY-LIPOPROTEIN APHERESIS 62
Expression of tissue factor and vascular endothelial growth factor in colorectal carcinoma 62
A ROLE FOR PLATELETS AND THROMBIN IN THE JUVENILE STROKE OF 2 SIBLINGS WITH DEFECTIVE THROMBIN-ADSORBING CAPACITY OF FIBRIN(OGEN) 61
Evidence that cells from experimental tumours can activate coagulation factor X. British journal of cancer. 61
Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues. 61
D-dimer corrected for thrombin and plasmin generation is a strong predictor of mortality in patients with sepsis 61
Cellular coagulation-fibrinolysis balance and atherosclerosis 60
Platelets abolish the profibrinolytic effect of activated protein C 60
PROPERTIES OF CHIMERIC (TISSUE-TYPE UROKINASE-TYPE) PLASMINOGEN ACTIVATORS OBTAINED BY FUSION AT THE PLASMIN CLEAVAGE SITE 60
Monoclonal antibodies targeting the antifibrinolytic activity of activated TAFI but not the anti-inflammatory activity on osteopontin and C5a 59
TISSUE FACTOR-EXPRESSING MONOCYTES INHIBIT FIBRINOLYSIS THROUGH A TAFI-MEDIATED MECHANISM, AND MAKE CLOTS RESISTANT TO HEPARINS 59
How a β-D-Glucoside Side Chain Enhances Binding Affinity to Thrombin of Inhibitors Bearing 2-Chlorothiophene as P1 Moiety: Crystallography, Fragment Deconstruction Study and Evaluation of Antithrombotic Properties 59
Influence of the fast-acting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue-type plasminogen activator in rabbits. Interference of tissue-derived components 57
Platelet aggregation and stimulation of leucocyte procoagulant activity by rickettsial lipopolysaccharides in rabbits and in man. 57
Procoagulant activity of mononuclear phagocytes from different anatomical sites in patients with gynecological malignancies 57
Cellular and plasmatic anomalies of the coagulation system and fibrinolysis in children with lymphomas and influence of cytostatic treatment 56
Estressione del tisuue factor e del vasular endothelial growth factor nel carcinoma del colon retto 56
Totale 7.948
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.600
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.600
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019827 0 0 0 0 0 0 0 0 0 0 418 409
2019/20202.830 498 161 64 276 319 180 295 265 368 115 218 71
2020/20211.488 144 104 126 70 169 102 118 146 171 203 83 52
2021/20221.185 57 201 11 40 64 51 63 54 81 63 202 298
2022/20231.826 265 197 135 165 216 236 24 174 331 13 36 34
2023/2024410 59 103 17 37 31 105 15 25 5 11 2 0
Totale 10.495